Sonia Delgado Céspedes
Sonia Delgado Céspedes is the newly appointed director of the Digemid, Peru's regulatory authority for health products. She has recently been in the news following the controversy surrounding defective physiological serum manufactured by Medifarma, which has raised questions about the efficiency and transparency of regulatory processes under her leadership.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Peru | 4 | 4.75 | 0.23% | +0% | 32,971,846 | 74,979 | $230,000 | 523$ |
| Panama | 1 | 4.00 | 0.11% | +0% | 4,314,768 | 4,605 | $76,000 | 81$ |
| Totals | 5 | 37,286,614 | 79,584 | $306,000 | 604$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Panama:
Sonia Delgado Céspedes served as the temporary replacement for Moisés Mendocilla Risco but was removed after 24 hours due to a conflict of interest.
4
Peru:
Sonia Delgado Céspedes was recently appointed as the director of the General Directorate of Medicines, Supplies, and Drugs.
5
Peru:
Sonia Delgado Céspedes was dismissed as director general of Digemid due to questions about a possible conflict of interest.
4
Peru:
Sonia Delgado defended herself by stating that she had no political affiliation or ties to the pharmaceutical sector for over two and a half years.
5
Peru:
Sonia Delgado Céspedes is the new director of the Digemid, facing scrutiny over her strategy to mitigate the possible shortage of saline solution.
5